Exchange: NASDAQ·Updated 07:30 PM EST

About EVMN

About

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
48

Frequently Asked Questions

Advertisement|Remove ads.